Organic growth drives Autonomy’s 3Q09 results to new levels

Software firm Autonomy Corporation plc reported third-quarter to end September net profit rose to $36.8m from $33.4m, while sales rose 51% to $191.6m from $127.1 million last year.

CEO Mike Lynch said: "We delivered strong growth despite the usual seasonality and challenging comparatives. These results give us confidence in maintaining our view of the full year."

Profit before tax reached a record $64.3m up 20% from $53.7m in the September 08 quarter.

The Cambridge-HQed company's share price slid 4% on the news, after recently scaling year highs. It is currently valued at around £3.6 billion, making it comfortably the most valuable publicly listed company with its home and roots in Silicon Fen.

Dr Lynch said the firm was "very busy in the quarter preparing for 2010.

"We successfully launched IDOL SPE, which was very positively received by the industry, and generated a stronger than expected demand on our Quick Start program.

"We have also invested in our data centre capacity to allow future growth in the Meaning Based Marketing (MBM) side of the business, which has already begun to show good traction.

"During the quarter we saw some of our large customers promote Autonomy to strategic supplier status. This has led them to adopt a broader set of our solutions in a number of significant deals."

He said cash generation of the business since the beginning of the year had been so strong that its cash balance already covers the remaining part of the debt it took out six months ago to fund the Interwoven acquisition.

"We feel that should an upturn start to materialise we are extremely well positioned to accelerate our growth."

 



Previous articles
ARM reports small growth in 1H08 revenue, slip in pretax profit in tough market conditions; market warms to outlook
Tadpole tumbles as key client reviews strategy; takes big hit on trading, funding
Briefs: LBO showing off miniature projectors; ANT trading well
Silicon Fen shorts: Amino Trading strongly; 6 Cambridge graduates win award, funding for novel ovulation detection technology
Cambridge MIT Institute happy to switch to virtual mode as Govt funding runs out
Autonomy's 'extraordinary' '06 sees revenues up 161%, operating profits soar 275%
Celsis Board recommends £54.5m offer
Briefs: PrismaStar launches online camera selector in US; new CFO for Intercytex
VNC offers 2-way remote control for mobile devices; CamiSemi launches new power charger chips
Snippets: Archer hands stem cells over to Hauser; Autonomy top corporate search firm
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Avlar BioVentures


Catherine Prescott
Science Director


Avlar BioVentures Ltd was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund I (£21m) and Avlar Fund II (£43m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought

[Avlar BioVentures's profile]


Top20 Index




Currently: 161